http://www.kezarlifesciences.com
Kezar Life Sciences, Inc. Company Intro
Industry
Healthcare
Kezar Life Sciences, Inc. Headquaters
4000 Shoreline Court
South San Francisco,94080
United States
Kezar Life Sciences, Inc. Share price
17 May 2023 13:27 GMT
$2.9800
-0.03 (-1.0 %)
Kezar Life Sciences, Inc. Market cap
$220.736 M
WMC RANKING
2023
Kezar Life Sciences, Inc. # 491
BiotechnologyLatest Kezar Life Sciences, Inc. News
01 Dec 2023
Autoimmune Hemolytic Anemia Therapeutics Industry Huge ...
Autoimmune Hemolytic Anemia Therapeutics Industry Huge Growth in Future Scope 2023-2029 | F. Hoffmann-La Roche Ltd, Incyte Corp, Kezar Life Sciences Inc. Leave...
01 Dec 2023
Autoimmune Hemolytic Anemia Therapeutics Industry Huge Growth in Future Scope 2023-2029 | F. Hoffmann-La ...
Marketintelx.com's latest published report provides global insights into the Autoimmune Hemolytic Anemia Therapeutics Market in 2022.
01 Dec 2023
Biopharma Layoff Tracker 2023: Orna, Kite, Candel and More Cut Staff
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
WMC Market Score
WMC Market to Revenue Score
Kezar Life Sciences, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Kezar Life Sciences, Inc. | USD | $0 | $45,520 | $-44,724 | $2,207M | 491 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Kezar Life Sciences, Inc. Social Followers vs Top 4 Industry Competitors
Kezar Life Sciences, Inc. Post vs Top 4 Industry Competitors
Kezar Life Sciences, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Kezar Life Sciences, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Kezar Life Sciences, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Kezar Life Sciences, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
